Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inclisiran vs Statin in Primary Aldosteronism
NCT07884955Recruiting
- Sponsor
- Army Medical University
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised trial of inclisiran in primary aldosteronism (PA) (2 arms), sponsored by Army Medical University. Primary endpoint: Change from baseline in plasma aldosterone level at 24 weeks. Started Oct 2026; status: recruiting.
02
Drugs
inclisiran
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT07884955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07884955.